Who uses the SmartLab system and what benefits have they reported?
VelQuest co-sponsors the annual International Meeting on Automated Compliance Systems (IMACS) where users report their experiences and management metrics. Typical benefits include 50-75% reduction in review cycle times and reporting, 20% + overall cost reductions usually achieved by significant reductions in review resources and large improvements in error reductions and overall cycle times for just-in-time manufacturing release initiatives. In analyzing the return on investments for this technology, typical returns are achieved in 6 months to 1.5 years depending on the environments. Reporting companies include: AstraZeneca, Bristol-Myers Squibb, Eli Lilly & Company, McNeil Consumer Healthcare, GlaxoSmithKline, Forest Labs, MedPointe Pharmaceuticals and many more. For more information on IMACS go to www.imacs-world.com.
